Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

3-m

3-m

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

2, 3-dihydronaphthalene m-diazabenzene compound as well as synthesis method, pharmaceutical composition and application of 2, 3-dihydronaphthalene m-diazabenzene compound
Applicant: SHANGHAI INST MATERIA MEDICA CASPriority: 2024
CN
ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 MICRONS TO ABOUT 10 MICRONS
Applicant: ALPHAPHARM PTY LTDPriority: 2008
CN
US
2 publications
Bevantolol drug intermediate 3-m-tolyloxy-1, 2-epoxypropane synthetic method
Applicant: CHENGDU QIESITE TECH CO LTDPriority: 2015
CN
2 publications
Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient
Applicant: COSMA S P APriority: 2002
EP
US
4 publications
m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRIN ALPHA-V BETA-3 ANTAGONISM
Applicant: MEIJI SEIKA KAISHAPriority: 2000
EP
M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity
Applicant: AJITO KEIICHIPriority: 2004
US
Method for preparing 7-phenylacetamido-3-chloromethyl-4-carboxylic acid p-m-ethoxybenzyl ester
Applicant: JIANGSU JIUJIUJIU TECH CO LTDPriority: 2008
CN
Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
Applicant: AFFINIUM PHARM INCPriority: 2013
US